These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27861334)

  • 1. Lactic acidosis and the relationship with metformin usage: Case reports.
    Huang W; Castelino RL; Peterson GM
    Medicine (Baltimore); 2016 Nov; 95(46):e4998. PubMed ID: 27861334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse event notifications implicating metformin with lactic acidosis in Australia.
    Huang W; Castelino RL; Peterson GM
    J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic Acidosis in Diabetic Population: Is Metformin Implicated? Results of a Matched Case-Control Study Performed on the Type 2 Diabetes Population of Grenoble Hospital University.
    Lepelley M; Giai J; Yahiaoui N; Chanoine S; Villier C
    J Diabetes Res; 2016; 2016():3545914. PubMed ID: 27034959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002967. PubMed ID: 16437448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin exposure and the incidence of lactic acidosis in critically ill patients with T2DM: A retrospective cohort study.
    Tong J; Li X; Liu T; Liu M
    Sci Prog; 2024; 107(3):368504241262116. PubMed ID: 39053014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Patients Die with or from Metformin-Associated Lactic Acidosis (MALA)? Systematic Review and Meta-analysis of pH and Lactate as Predictors of Mortality in MALA.
    Blumenberg A; Benabbas R; Sinert R; Jeng A; Wiener SW
    J Med Toxicol; 2020 Apr; 16(2):222-229. PubMed ID: 31907741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactic acidosis. Lactic acidosis associated with metformin use in treatment of type 2 diabetes mellitus.
    DePalo VA; Mailer K; Yoburn D; Crausman RS
    Geriatrics; 2005 Nov; 60(11):36, 39-41. PubMed ID: 16287340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study.
    Aharaz A; Pottegård A; Henriksen DP; Hallas J; Beck-Nielsen H; Lassen AT
    PLoS One; 2018; 13(5):e0196122. PubMed ID: 29738540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acidosis in medical ICU - the role of diabetes mellitus and metformin.
    Hloch O; Charvat J; Masopust J; Havlin J
    Neuro Endocrinol Lett; 2012; 33(8):792-5. PubMed ID: 23391971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter Posthumous EE
    Cochrane Database Syst Rev; 2010 Jan; (1):CD002967. PubMed ID: 20091535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult metformin toxicity in three patients with profound lactic acidosis.
    Perrone J; Phillips C; Gaieski D
    J Emerg Med; 2011 Mar; 40(3):271-5. PubMed ID: 18571361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology physiology conference: metformin and lactic acidosis (LA).
    Alkhalil C; Zavros G; Bailony F; Lowenthal DT
    Int Urol Nephrol; 2002; 34(3):419-23. PubMed ID: 12899240
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus.
    Hitchings AW; Archer JR; Srivastava SA; Baker EH
    COPD; 2015 Apr; 12(2):126-31. PubMed ID: 25938184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality rate in so-called "metformin-associated lactic acidosis": a review of the data since the 1960s.
    Kajbaf F; Lalau JD
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1123-7. PubMed ID: 25079826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter study.
    Corchia A; Wynckel A; Journet J; Moussi Frances J; Skandrani N; Lautrette A; Zafrani L; Lewandowski E; Reboul P; Vrigneaud L; Djerada Z; Rieu P
    Clin Toxicol (Phila); 2020 May; 58(5):375-382. PubMed ID: 31387415
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
    Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
    Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan.
    Chang CH; Sakaguchi M; Dolin P
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1196-1203. PubMed ID: 27221971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Metformin-Associated Lactic Acidosis (MALA) in Patients After Gastric Bypass Surgery.
    Deden LN; Aarts EO; Aelfers SCW; van Borren MMGJ; Janssen IMC; Berends FJ; de Boer H
    Obes Surg; 2018 Apr; 28(4):1080-1085. PubMed ID: 29058235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.